Heidy King-Jones

See Remarks, Spyre Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$5.1M

Companies

Latest trade

Oct 1, 2026

Companies

Spyre Therapeutics, Inc.See Remarks −$5.1M

Trades

SYRE Sold 28,933 shares at $91.03 · planned $2.6M Oct 1

SYRE Sold 400 shares at $90.00 · planned $0.0M Sep 2

SYRE Sold 27,999 shares at $87.31 · planned $2.4M Sep 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.